HOME >> MEDICINE >> NEWS
Brookhaven Lab and BioSET develop a synthetic peptide that enhances the effect of BMP-2

al benefit."

The growth factor analogs developed in the Brookhaven/BioSET collaboration are synthetic peptides that are chemically more stable and easier to produce than natural growth factors or growth factors derived by recombinant protein techniques. BioSET has an exclusive license to develop and market these bioactive analogs.

Thomas Rouech, BioSET's president, said, "We are fortunate to enjoy a fruitful collaboration. This class of peptide and others under development supports the concept of design-targeted synthetic peptides for specific tissue regeneration applications. The Brookhaven/BioSET collaboration continues to yield very promising results aimed at replicating human growth factors, and we look forward to further validating the potential of these peptides to enhance the body's healing capacity, especially when combined with orthopedic implants."

He added, "We believe the future of orthopedics will continue evolving towards combination products, such as devices that have been biologically enhanced. For example, approved growth factor-type combination device products are currently valued at over $1.6 billion. Our ability to bring new bioactive peptides into the mix of new product development positions us at the leading edge of an important evolution in orthopedic medicine."


'"/>

Contact: Diane Greenberg
greenb@bnl.gov
631-344-2347
DOE/Brookhaven National Laboratory
9-Nov-2004


Page: 1 2

Related medicine news :

1. Brookhaven spotlights: News from the March 2003 American Chemical Society Meeting
2. Brookhaven lab scientist wins Glenn T. Seaborg Award for Nuclear Chemistry
3. Late developers may run higher risk of infection than sexually mature younger teens
4. Hospital acquired infections present major problem for infants in developing countries
5. Targeting mutant B-Raf protein reduces melanoma development
6. Liverpool to lead 20M Department of Health initiative to develop medicines for children
7. Helping answer needs by developing specialists in autism
8. Common anesthetics appear safe for developing fetal brain
9. UCSD-Utah team develops mouse model to test therapies for macular degeneration
10. Hopkins convenes consensus conference to develop blueprint for nationwide matching program
11. Daily supplement may boost birthweight of babies in the developing world

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/22/2018)... Fla. (PRWEB) , ... July 20, 2018 , ... Dr. ... developing groundbreaking medical devices for cardiology patients after retiring and resigning as a part-time ... Medicine. , “I have enjoyed serving on the Johns Hopkins faculty for ...
(Date:7/22/2018)... ... ... Los Angeles based online plastic surgery and information community, is ready to make finding doctors ... of lists that spotlight the “ Best San Diego Doctors ” for a variety of ... Diego is often referred to as America’s finest city by those who live in the ...
(Date:7/22/2018)... ... July 22, 2018 , ... HealthyChildren.org, the ... new issue of Healthy Children , a digital-only magazine for smartphones and ... Back-to-School issue helps parents prepare for the new school year. , The ...
(Date:10/13/2017)... ... ... As health professionals work to improve their approach to healthcare, there is ... than filling out a survey; in many cases health professionals and patients are working ... and research on the importance of active engagement with patients and members of the ...
(Date:10/13/2017)... ... ... PurhealthRX , a leading Health and Nutrition Company, is announcing the ... spectrum CBD oil will revolutionize the rapidly growing CBD market by reducing the amount ... into liquid products, while reducing costs to end users. , The team of researchers ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Halo Labs announces the European launch of their new ... at MIBio 2017 in Cambridge, U.K on ... in biopharmaceutical samples with unprecedented speed and sensitivity while using far ... Membrane Imaging. ... particle analysis system ...
(Date:9/27/2017)... -- Commended for their devotion to personalized service, SMP Pharmacy Solutions ... in the South Florida Business Journal,s 50 Fastest-Growing Companies, and ... the national specialty pharmacy has found its niche.  To that ... be honored by SFBJ as the 2017 Power Leader in ... receive his award in October, Bardisa said of the three ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
Breaking Medicine Technology:
Cached News: